In cooperation with Novo Nordisk International Healthcare Company, Center of Hematology, University of Al-Mustansiriyah held a symposium on the latest developments in the field of diagnosis and treatment of hereditary hemorrhagic diseases.

The symposium, in which a number of doctors and specialists participated, highlighted the drug of the seventh factor which is used to treat hereditary hemorrhage and it is in form of dissolved solution.

The symposium reviewed the steps to stop the bleeding by taking the seventh factor drug and for the patients with hemophilia (factor VIII deficiency with the presence of inhibitors or factor VII) As well as the drug modern characteristics to be taken by syringe.

Load More In News of Universities
Load More Related Articles